Tag: patient adherence

The FDA Is Making Biosimilars Easier to Approve. But Will Patients Actually Use Them?

Post author By Hoot
Post date March 16, 2026

Last week, the FDA released new draft guidance designed to streamline the development of biosimilar drugs by removing certain testing requirements. The goal is to accelerate competition and make biologic therapies more affordable. At first glance, this may appear to be a purely regulatory update. In reality, it highlights a much larger issue in healthcare. […]

Tags biosimilar adoption, biosimilars, FDA biosimilar guidance, patient adherence, pharma patient education

Why Physician-Led Education Is the Most Powerful Driver of Therapy Starts and Adherence

Post author By Hoot
Post date March 4, 2026

Every year, millions of prescriptions are written that patients never start. Some patients never pick up their medication. Others start therapy but stop within weeks. For healthcare systems, pharmaceutical companies, and providers alike, this represents one of the most expensive and preventable failures in modern medicine. In the United States alone, roughly one in four […]

Tags patient adherence, Patient Education, pharma patient services, physician communication, therapy initiation

Pharma Is Losing $250 Billion to Patient Dropout. Here’s the Fix the Industry Can’t Ignore

Post author By Hoot
Post date February 25, 2026

Today we released a press announcement that addresses something pharma leaders already feel in their forecasts, but rarely quantify directly: Patient dropout is quietly draining $250 billion from the U.S. pharmaceutical market every year. You can read the full announcement here:https://www.prnewswire.com/news-releases/pharma-is-losing-250-billion-to-patient-dropout-heres-how-to-stop-it-302696178.html Not because therapies do not work. Not because innovation has slowed. But because patients […]

Tags patient adherence, Patient Education, pharma strategy, pharmaceutical commercialization, therapy persistence